Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 183 for lung disease

Edit search filters
  1. A Study of the Efficacy and Safety of Belimumab Compared to Placebo in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    Scottsdale/Phoenix, AZ

  2. A Study Comparing the Effectiveness of Tiotropium and Olodaterol in Fixed Dose Combination Over Tiotropium Alone in Reducing Moderate to Severe Wosening of Symptoms in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease

    Rochester, MN

  3. Study of TJ011133 in Participants With Relapsed/ Refractory Advanced Solid Tumors and Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. MEDI5395 Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

    Rochester, MN, Scottsdale/Phoenix, AZ

  6. A Study to Evaluate the Effectiveness and Safety of Rivaroxaban as Prophylaxis Treatment for Venous Thromboembolism (VTE) in Ambulatory Cancer Patients

    Rochester, MN

  7. A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Rochester, MN

  8. Understanding the Challenges, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials in Minority Patient Populations

    Jacksonville, FL, Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study of HFB200301 in Adult Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer